Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:ATC_code
|
| gptkbp:activeIngredient |
gptkb:ozanimod
|
| gptkbp:ATC_level |
5
|
| gptkbp:ATC_prefix |
gptkb:L04AC
|
| gptkbp:belongs_to_anatomical_group |
L - Antineoplastic and immunomodulating agents
|
| gptkbp:belongs_to_chemical_subgroup |
L04AC - Selective immunosuppressants
|
| gptkbp:belongs_to_pharmacological_subgroup |
L04A - Immunosuppressants
|
| gptkbp:belongs_to_therapeutic_subgroup |
L04 - Immunosuppressants
|
| gptkbp:bfsParent |
gptkb:risankizumab
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
L04AC21
|